Personalized Neo-Antigen Peptide Vaccine
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Personalized Neo-Antigen Peptide Vaccine, covering 2026-03-12 to 2026-03-12. Get the full timeline:
Most recent: Clinical Trial Update: Personalized Neo-Antigen Peptide Vaccine for the Treatment of Stage IIIC-IV Melanoma, Hormone Receptor Positive HER2 Negative Metastatic Refractory Breast Cancer or Stage III-IV Non-Small Cell Lung Cancer [Phase 1]